 |
|
Psyllium for the Reduction of Cholestyramine-Associated Gastrointestinal Symptoms in the Treatment of Primary Hypercholesterolemia
James J. Maciejko, MS, PhD;
Ronald Brazg, MD;
Aajay Shah, MD;
Sanjay Patil, MD;
Melvyn Rubenfire, MD
Arch Fam Med. 1994;3(11):955-960.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results, I: reduction in incidence of coronary heart disease. JAMA. 1984;251:351-364.
FREE FULL TEXT
2. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987;257:3233-3240.
FREE FULL TEXT
3. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289-1298.
PUBMED
4. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA. 1990;264:3007-3012.
FREE FULL TEXT
5. National Cholesterol Education Program Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program Expert (NCEP) Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
FREE FULL TEXT
6. Blum CB, Levy RI. Current therapy for hypercholesterolemia. JAMA. 1989;261:3582-3587.
FREE FULL TEXT
7. Anderson JW, Zettwoch N, Feldman T, Tietyen-Chen J, Oeltgen P, Bishop CW. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med. 1988;148:292-296.
FREE FULL TEXT
8. Bell LP, Hectorne K, Reynolds H, Balm TK, Hunninghake DB. Cholesterollowering effects of psyllium hydrophilic mucilloid: adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA. 1989;261:3419-3423.
FREE FULL TEXT
9. Rubenfire M, Maciejko JJ, Blevins RD, Orringer C, Kobylak L, Rosman H. The effect of pravastatin on plasma lipoprotein and apolipoprotein levels in primary hypercholesterolemia. Arch Intern Med. 1991;151:2234-2240.
FREE FULL TEXT
10. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
FREE FULL TEXT
11. Kruse WHH. Compliance with treatment of hyperlipoproteinemia in medical practice and clinical trials. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York, NY: Raven Press; 1991:175-186. 12. Levin EG, Miller VT, Muesing RA, Stoy DB, Balm TK, LaRosa JC. Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med. 1990;150:1822-1827.
FREE FULL TEXT
13. Neal GW, Balm TK. Synergistic effects of psyllium in the dietary treatment of hypercholesterolemia. South Med J. 1990;83:1131-1137.
PUBMED
14. Hunninghake DB. Bile acid sequestrants. In: Rifkind BM, ed. Drug Treatment of Hyperlipidemia. New York, NY: Marcel Dekker Inc; 1991:89-102.
|
